arrow
D

Dominik Mertz

Hamilton Health Sciences
H指数:48
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing inter-rater agreement within a point prevalence survey of healthcare-associated infections and antimicrobial use in Canadian acute care hospitals

评估加拿大急性护理医院中医疗相关感染和抗菌药物使用现况调查中的评定者间一致性

2026-09-280
OA
Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) randomised controlled trial

达比加群抗凝在金黄色葡萄球菌菌血症中是否有作用?——金黄色葡萄球菌网络适应性平台(SNAP)随机对照试验辅助治疗领域的方案

2025-12-110
OA
The Burden of Surgical Site Infections With Pathogens Presumably Resistant to Perioperative Prophylaxis in Orthopedic Tumor Surgery: Secondary Analysis of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Trial

骨科肿瘤手术中,对假定性耐药于围手术期预防性抗生素的病原体所致手术部位感染的负担:肿瘤手术预防性抗生素方案(PARITY)试验的二次分析

2025-10-010
PRE
Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2024
2025-10-010
OAAI
Trends in healthcare-associated infections and antimicrobial-resistant organisms among adults in Canadian acute care hospitals: findings from four point prevalence surveys, 2002 to 2024

加拿大急性护理医院成人中与医疗相关的感染和抗菌药物耐药菌的趋势:2002年至2024年四次点患病率调查的结果

2025-09-010
OAAI
Metaresearch on patient-reported outcomes in trial protocols and results publications suggested large outcome reporting bias

对试验方案和结果出版物中患者报告结局的元研究表明,存在显著的结果报告偏倚。

2025-05-090
OA
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections

世卫组织的基本药物和AWaRe: 关于经验性治疗临床感染的第一和第二选择抗生素的建议

2024-04-0111
OA
Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study
2023-09-012
PRE